Bill > HR4132

This bill aims to modernize the way prescription drug information is communicated by allowing pharmaceutical manufacturers to provide prescribing information solely through electronic means for certain drugs regulated under the Federal Food, Drug, and Cosmetic Act. The bill requires that manufacturers still offer healthcare professionals the option to receive paper copies of prescribing information upon request, at no additional cost. Within one year of the Act's enactment, the Department of Health and Human Services must issue regulations implementing this electronic communication approach, with specific instructions for healthcare professionals to obtain paper copies if desired. The regulations must be designed to minimize economic impacts on prescribers and dispensers. Additionally, the FDA is mandated to host a public workshop within two years to discuss further improvements to the format, accessibility, and usability of prescribing information. The new electronic prescribing information approach will take effect two years after the Act's enactment or when final regulations are implemented, whichever comes first. This legislation represents an effort to streamline drug information distribution while maintaining accessibility for healthcare professionals through a flexible, technology-enabled approach.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/4132/all-info